Halyard Health (HYH) Misses Q3 EPS by 20c; Boosts EPS Outlook

November 2, 2016 7:23 AM EDT

Get access to the best calls on Wall Street with StreetInsider.com's Ratings Insider Elite. Get your Free Trial here.

Halyard Health (NYSE: HYH) reported Q3 EPS of $0.19, $0.20 worse than the analyst estimate of $0.39. Revenue for the quarter came in at $398 million versus the consensus estimate of $387.64 million.

GUIDANCE:

Halyard Health sees FY2016 EPS of $1.87-$1.97, versus prior guidance of $1.70-$1.90 and the consensus of $1.82.

For earnings history and earnings-related data on Halyard Health (HYH) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Earnings, Guidance

Related Entities

Earnings

Add Your Comment